Proteomic identification of 14-3-3ζ as a mitogen-activated protein kinase-activated protein kinase 2 substrate: Role in dimer formation and ligand binding

Molecular and Cellular Biology

Volumn 23, Issue 15, 2003, Pages 5376-5387

  Powell, David W ^a   Rane, Madhavi J ^b   Joughin, Brian A ^d   Kalmukova, Ralitsa ^d   Hong, Jeong Ho ^d   Tidor, Bruce ^d   Dean, William L ^a   Pierce, William M ^a   Klein, Jon B ^a,b,c   Yaffe, Michael B ^d   McLeish, Kenneth R ^a,b,c  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED PROTEIN KINASE 2; RAF PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; DIMERIZATION; DNA FINGERPRINTING; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; NEUTROPHIL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; STIMULATION;

14-3-3 PROTEINS; AMINO ACID SEQUENCE; CELL LINE; DIMERIZATION; DNA MUTATIONAL ANALYSIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENETIC VECTORS; GLUTATHIONE TRANSFERASE; HUMANS; LIGANDS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTEOME; PROTO-ONCOGENE PROTEINS C-RAF; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SOFTWARE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTRATE SPECIFICITY; TRYPSIN; TYROSINE 3-MONOOXYGENASE;

EID: 0043092653     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.15.5376-5387.2003     Document Type: Article

References (42)

1. Aitken, A., S. Howell, D. Jones, J. Madrazo, and Y. Patel. 1995. 14-3-3 alpha and delta are the phosphorylated forms of Raf-activating 14-3-3 beta and zeta. J. Biol. Chem. 270:5706-5709.
2. Aitken, A., S. Howell, D. Jones, J. Madrazo, H. Martin, Y. Patel, and K. Robinson. 1995. Post-translationally modified 14-3-3 isoforms and inhibition of protein kinase C. Mol. Cell. Biochem. 149-150:41-49.
3. Cheng, T., and Y. Lai. 1998. Identification of mitogen-activated protein kinase-activated protein kinase as vimentin kinase activated by okadaic acid in 9L rat brain tumor cells. J. Cell Biochem. 71:169-181.
4. Coxon, P. Y., M. J. Rane, S. Uriarte, D. W. Powell, S. Singh, W. Butt, Q. Chen, and K. R. McLeish. MAPK-activated protein kinase-2 participates in p38-dependent and ERK-dependent functions in human neutrophils. Cell. Signal., in press.
5. Dubois, T., C. Rommel, S. Howell, U. Steinhussen, Y. Soneji, N. Morrice, K. Moelling, and A. Aitken. 1997. 14-3-3 is phosphorylated by casein kinase I on residue 232. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction. J. Biol. Chem. 272:28882-28888.
6. Engel, K., H. Schultz, F. Martin, A. Kotlyarov, K. Plath, M. Hahn, U. Heinemann, and M. Gaestel. 1995. Constitutive activation of mitogen-activated protein kinase-actived protein kinase 2 by mutation of phosphorylation sites and an A-helix motif. J. Biol. Chem. 270:27213-27221.
7. Fagerholm, S., N. Morrice, C. Gahmberg, and P. Cohen. 2002. Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes. J. Biol. Chem. 277:1728-1738.
8. Frasch, C., J. Nick, V. Fadok, D. Bratton, S. Worthen, and P. Henson. 1998. p38 mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273:8389-8397.
9. Hannigan, M., L. Zhan, Y. Ai, and C. Huang. 2001. Leukocyte-specific gene 1 protein (LSP1) is involved in chemokine KC-activated cytoskeletal reorganization in murine neutrophils in vitro. J. Leukoc. Biol. 69:497-504.
10. -/- neutrophils in Zigmond chambers containing formyl-methionyl-leucyl-phenylalanine gradients. J. Immunol. 167:3953-3961.
11. Haslett, C., L. Guthrie, M. Kopaniak, J. Johnston, and P. Henson. 1985. Modulation of multiple neutrophil functions by preparative methods of trace concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 119:101-110.
12. Huang, C., L. Zhan, Y. Ai, and J. Jongstra. 1996. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J. Biol. Chem. 272:17-19.
13. Jackson, J., B. Bolognese, L. Hillegass, S. Kassis, J. Adams, D. Griswold, and J. Winkler. 1998. Pharmacological effects of SB220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J. Pharmacol. Exp. Ther. 284:687-692.
14. Jensen, O., M. Wilm, A. Shevchenko, and M. Mann. 1999. Sample preparation methods for mass spectrometric peptide mapping directly from 2-DE gels. Methods Mol. Biol. 112:513-530.
15. Jongstra-Bilen, J., V. Misener, C. Wang, H. Ginzberg, A. Auerbach, A. Joyner, G. Downey, and J. Jongstra. 2000. LSP1 modulates leukocyte populations in resting and inflamed peritoneum. Blood 96:1827-1835.
16. Kangas, E., and B. Tidor. 1999. Charge optimization leads to favorable electrostatic binding free energy. J. Chem. Phys. 109:7522-7545.
17. Karplus, M. 2002. Molecular dynamics simulations of biomolecules. Acc. Chem. Res. 35:321-323.
18. Kiemer, A., N. Weber, R. Furst, N. Bildner, S. Kulhanek-Heinze, and A. Vollmar. 2002. Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ. Res. 90:874-881.
19. Klein, J., M. Rane, J. Scherzer, P. Coxon, R. Kettritz, J. Mathiesen, A. Buridi, and K. McLeish. 2000. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J. Immunol. 164:4286-4291.
20. Kotlyarov, A., A. Neininger, C. Schubert, R. Eckert, C. Birchmeirer, H. Volk, and M. Gaestel. 1999. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1:94-97.
21. Lee, L., and B. Tidor. 2001. Optimization of binding electrostatics: charge complementarity in the barnase-barstar protein complex. Protein Sci. 10:362-377.
22. Liu, D., J. Bienkowska, C. Petosa, J. Collier, H. Fu, and R. Liddington. 1995. Crystal structure of the zeta isoforms of the 14-3-3 protein. Nature 376:191-194.
23. Luo, Z., X. Zhang, U. Rapp, and J. Avruch. 1995. Identification of the 14.3.3ζ domains important for self-association and Raf binding. J. Biol. Chem. 270:23681-23687.
24. Mahtani, K. R., M. Brook, J. L. E. Dean, G. Sully, J. Saklatvala, and A. R. Clark. 2001. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21:6461-6469.
25. McLeish, K., C. Knall, R. Ward, P. Gerwins, P. Coxon, J. Klein, and G. Johnson. 1998. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF. J. Leukoc. Biol. 64:537-545.
26. Megidish, T., J. Cooper, L. Zhang, H. Fu, and S. Hakomori. 1998. A novel sphingosine-dependent protein kinase (SDK1) specifically phosphorylates certain isoforms of 14-3-3 protein. J. Biol. Chem. 273:21834-21845.
27. + T cells. Mol. Cell. Biol. 20:936-946.
28. Nahas, N., T. Molski, G. Fernandez, and R. Sha'afi. 1996. Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem. J. 318:247-253.
29. Nick, J., N. Avdi, S. Young, C. Knall, P. Gerwins, G. Johnson, and S. Worthen. 1997. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Investig. 99:975-986.
30. Nick, J., N. Avdi, S. Young, L. Lehman, P. McDonald, S. Frasch, M. Billstrom, P. Henson, G. Johnson, and S. Worthen. 1999. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J. Clin. Investig. 103:851-858.
31. Ono, K., and J. Han. 2000. The p38 signal transduction pathway activation and function. Cell. Signal. 12:1-13.
32. Powell, D., M. Rane, Q. Chen, S. Singh, and R. McLeish. 2002. Identification of 14-3-3ζ as a protein kinase B/Akt substrate. J. Biol. Chem. 277:21639-21642.
33. Rane, M., P. Coxon, D. Powell, R. Webster, J. Klein, W. Pierce, P. Ping, and K. McLeish. 2001. P38 kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J. Biol. Chem. 276:3517-3523.
34. Rincon, M., H. Enslen, J. Raingeaud, M. Recht, T. Zapton, M. Su, L. Penix, R. Davis, and R. Flavell. 1998. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17:2817-2829.
35. Sitkoff, D., K. Sharp, and B. Honig. 1994. Correlating solvation free energies and surface tensions of hydrocarbon solutes. Biophys. Chem. 51:397-403.
36. Tzivion, G., L. Zhijun, and J. Avruch. 1998. A dimer 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394:88-92.
37. Underwood, D., R. Osborn, S. Bochnowicz, E. Webb, D. Rienman, D. Lee, A. Romanic, J. Adams, D. Hay, and D. Griswold. 2000. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:895-902.
38. van Hermert, M., H. Steensma, and P. van Heusden. 2001. 14-3-3 proteins: key regulators of cell division, signaling, and apoptosis. BioEssays 23:936-946.
39. Ward, R., M. Nakamura, and K. McLeish. 2000. Priming of the neutrophil respiratory burst involves p38 mitogen-activated protein kinase-dependent exocytosis of flavocytochrome b558-containing granules. J. Biol. Chem. 275:36713-36719.
40. Werz, O., J. Klemm, B. Samuelsson, and O. Radmark. 2000. 5-Lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases. Proc. Natl. Acad. Sci. USA 97:5262-5266.
41. Yaffe, M., K. Rittinger, S. Volinia, P. Caron, A. Aitken, H. Leffers, S. Gamblin, S. Smerdon, and L. Cantley. 1997. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 91:961-971.
42. Zu, Y., Y. Ai, A. Gilchrist, M. Labadia, R. Sha'afi, and C. Haung. 1996. Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester of fMLP peptide stimulation. Blood 87:5287-5296.